| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |